Sfoglia per AUTORE
BALESTRI R
Collezione ASL Biella

  

Items : 3

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria
ASL Biella

Torri V; Fusco V; Ercolani G; Traverso E; Cavaliere D; Solaini L; Balestri R; Ceccarelli C; Buccianti P; Coratti A; Menegatti B; Perna F; Mammano E; Contardo T; Morpurgo E; De Nisco C; Pulighe F; Pernazza G; Ruffo G; Gori S; Bertocchi E; Alongi F; Perinotti R; Rosati R; Elmore U; Delpini R; Boni L; Baldari L; Cassinotti E; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Franzone P; Numico G; Priora F; Rossi M; Fusco V; Traverso E; Torri V; Ercolani G; Solaini L; Cavaliere D; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Menegatti B; Coratti A; Perna F; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; Morpurgo E; Perinotti R; De Nisco C; Pernazza G; Pulighe F; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Numico G; Franzone P; Priora F; Rossi M; Traverso E; Fusco V; Solaini L; Torri V; Ercolani G; Cavaliere D; Ceccarelli C; Buccianti P; Balestri R; Perna F; Coratti A; Menegatti B; Baroffio P; Gentilli S; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; De Nisco C; Perinotti R; Morpurgo E; Pulighe F; Baldari L; et alii...